Patient Perceptions and Willingness to Enroll in Clinical Trials
Overview
The objective of our study is to determine which factors affect willingness to participate in gynecologic oncology clinical trials. Women with a diagnosis of gynecologic malignancy will be approached to complete a survey assessing willingness to participate in clinical trials. The validated Attitudes and Randomized Trials Questionnaire (ARTQ) will be used to assess willingness to participate.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: May 1, 2018
Interventions
- Other: Survey
- Attitudes and Randomized Trial Questionnaire (ARTQ), Hospital Anxiety and Depression Scale, Perception Survey
Arms, Groups and Cohorts
- Study Population
- Women with a gynecologic malignancy will complete several surveys to assess their willingness to participate in clinical trials.
Clinical Trial Outcome Measures
Primary Measures
- Willingness to Participate in Clinical Trials
- Time Frame: 6 months
- Bivariate outcome derived from ARTQ survey
Participating in This Clinical Trial
Inclusion Criteria
- Diagnosis of gynecologic malignancy – English or Spanish literate Exclusion Criteria:
- Prior enrollment in a clinical trial – Currently pregnant – Currently incarcerated
Gender Eligibility: Female
Minimum Age: 18 Years
Maximum Age: 90 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- University of Virginia
- Provider of Information About this Clinical Study
- Principal Investigator: Linda R Duska, Professor, Department of Obstetrics and Gynecology – University of Virginia
- Overall Official(s)
- Linda Duska, MD, MPH, Principal Investigator, University of Virginia
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.